Mardi Dier, EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 6,235 shares at $574.00 ($3.6M) on 2025-12-02, disclosed to the SEC on 2025-12-03.
Scheduled sale ($3.6M) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $570.39 | 320 | $183K | 5.1% |
| 2 | $570.39 | 320 | $183K | 5.1% |
| 3 | $571.99 | 410 | $235K | 6.5% |
| 4 | $571.99 | 410 | $235K | 6.5% |
| 5 | $573.02 | 354 | $203K | 5.6% |
| 6 | $573.02 | 354 |
| $203K |
| 5.6% |
| 7 | $574.00 | 717 | $412K | 11.4% |
| 8 | $574.95 | 120 | $69K | 1.9% |
| 9 | $576.15 | 240 | $138K | 3.8% |
| 10 | $577.81 | 320 | $185K | 5.1% |
| 11 | $577.81 | 320 | $185K | 5.1% |
| 12 | $578.83 | 258 | $149K | 4.1% |
| 13 | $578.83 | 258 | $149K | 4.1% |
| 14 | $579.85 | 480 | $278K | 7.7% |
| 15 | $585.44 | 240 | $141K | 3.9% |
| 16 | $585.44 | 240 | $141K | 3.9% |
| 17 | $587.85 | 240 | $141K | 3.9% |
| 18 | $589.65 | 160 | $94K | 2.6% |
| 19 | $590.37 | 160 | $94K | 2.6% |
| 20 | $590.37 | 160 | $94K | 2.6% |
| 21 | $595.20 | 74 | $44K | 1.2% |
| 22 | $596.19 | 80 | $48K | 1.3% |
| Total | $577.79 avg | 6,235 | $3.6M | 100% |
| Filing → |
| MDGL | SELL | 2025-03-12 | $167K | — | Filing → |
| MDGL | SELL | 2025-03-05 | $1.3M | — | Filing → |
| SLRN | BUY | 2023-05-11 | $116K | — | Filing → |